Eli Lilly and Co
XETRA:LLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eli Lilly and Co
XETRA:LLY
|
US |
|
F
|
Fidelity National Information Services Inc
SWB:ZGY
|
US |
|
T
|
Tyson Foods Inc
SWB:TF7A
|
US |
|
Mitsubishi Corp
F:MBI0
|
JP |
|
Sysco Corp
NYSE:SYY
|
US |
|
M
|
Mitsubishi Corp
DUS:MBI
|
JP |
Wall St Price Targets
LLY Price Targets Summary
Eli Lilly and Co
According to Wall Street analysts, the average 1-year price target for LLY is 1 035.91 EUR with a low forecast of 729.69 EUR and a high forecast of 1 338.69 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LLY's stock price target?
Price Target
1 035.91
EUR
According to Wall Street analysts, the average 1-year price target for LLY is 1 035.91 EUR with a low forecast of 729.69 EUR and a high forecast of 1 338.69 EUR.
What is the Revenue forecast for Eli Lilly and Co?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 11%.
What is the Operating Income forecast for Eli Lilly and Co?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 8 years is 14%.
What is the Net Income forecast for Eli Lilly and Co?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 17%.
